Advancing Sexual and Reproductive Health and Rights
 
Perspectives on Sexual and Reproductive Health
Volume 45, Number 3, September 2013
VIEWPOINT

Insurance and Access Implications of an Over-the-Counter Switch for a Progestin-Only Pill

By Jennifer McIntosh, Britt Wahlin, Kate Grindlay, Myra Batchelder and Daniel Grossman

DOI:10.1363/4516413







 

AUTHOR AFFILIATIONS

Jennifer McIntosh is visiting researcher at the Department of Pharmacy, Hospital ClĂ­nic, Barcelona, Spain. Britt Wahlin is director of development and communications, and Kate Grindlay is senior project manager, both at Ibis Reproductive Health, Cambridge, MA. Myra Batchelder is reproductive health consultant. Daniel Grossman is vice president for research, Ibis Reproductive Health, and assistant clinical professor, Department of Obstetrics, Gynecology and Reproductive Sciences, University of California, San Francisco.